Autopsy report · NCT05155332

A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

“Sponsor decision - temporary enrolment hold as a precautionary measure following a safety event.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Suspended: paused, and may or may not restart.
• 190 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Phase 1

Sponsor

Boehringer Ingelheim

Sponsor type

Industry

Conditions

Solid Tumors

Interventions

BI 1831169; anti-PD-1 antibody

Participants

190 (planned, not actual)

Sites

33

Countries

Australia, Austria, Belgium, Canada, France, Germany, Italy, Spain, Switzerland, United States

Trials that died the same way

• A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)
  “Temporary enrolment hold as a precautionary measure following a safety event in a related trial” (81% match in meaning)
• NT-I7 in Combination With Atezolizumab in Previously Untreated, PD-L1-expressing, Locally Advanced or Metastatic NSCLC
  “sponsor decision (not for safety)” (78% match in meaning)
• A Evaluation of 3D Functional MIRA System in Women With Mammographically Dense Breasts
  “Sponsor decision, not safety related” (77% match in meaning)
• Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma
  “Sponsor decision (not due to safety concerns)” (77% match in meaning)
• An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEE
  “Sponsor decision; not a safety decision” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.